Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

January 10, 2025

Study Completion Date

January 10, 2025

Conditions

Lower Extremity Chronic Venous UlcersVaricose Veins LegHernia

Interventions

DRUG

Tramadol

Intravenous tramadol

DRUG

Magnesium sulphate

Intravenous magnesium sulphate

OTHER

Saline

Normal saline

All Listed Sponsors

lead

Al-Azhar University

OTHER

NCT06612996 - Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering | Biotech Hunter | Biotech Hunter